miRcutis owns and has access to a portfolio of intellectual property related to microRNAs, their mechanism of action, and analysis and methods of assay. This portfolio includes patents, patent applications, and licenses. The Company focuses on intellectual property which provides for and protects the basis for development of products for the skin, including both cosmetic applications and for clinical purposes. It also continuously monitors development in appropriate skin science for the purposes of potential acquisition, licensing, or collaboration.